HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

13,14-Dihydro-15-keto-pgd2

HCID 5283036
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
59894-07-4
Standard SMILES
CCCCCC(=O)CC[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
InChIKey
VSRXYLYXIXYEST-KZTWKYQFSA-N
Molecular formula
C20H32O5
Average molar mass
352.5 g/mol
Monoisotopic mass
352.22497412

Overview

13,14-dihydro-15-ketoprostaglandin D2 is a prostaglandin D that is prostaglandin D2 with a keto substituent replacing a hydroxy at position 15. It has a role as a metabolite. It is functionally related to a prostaglandin D2.

Names & identifiers

Preferred name
13,14-Dihydro-15-keto-pgd2
IUPAC
(Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
English name
13,14-Dihydro-15-keto prostaglandin d2
Molecular formula
C20H32O5
Molecular weight
352.47

Names & synonyms

13,14-Dihydro-15-keto-pgd259894-07-413,14-Dihydro-15-ketoprostaglandin D213,14-Dihydro-15-keto-prostaglandin D2(Z)-7-[(1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid11,15-dioxo-9S-hydroxy-5Z-prostenoic acidULX4SW2MF7Prost-5-en-1-oic acid, 9-hydroxy-11,15-dioxo-, (5Z,9alpha)-(Z)-7-((1R,2R,5S)-5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl)hept-5-enoic acidRefChem:7836713,14-DIHYDRO-15-KETO PROSTAGLANDIN D2MFCD00885499
Show more names
13,14-Dihydro-15-ketoprostadlandin D213,14-dihydro-15-keto Prostaglandin D9ALPHA-HYDROXY-11,15-DIOXO-PROST-5Z-EN-1-OIC ACID(5Z,9α)-9-Hydroxy-11,15-dioxoprost-5-en-1-oic acid13,14-dihydro-15-keto Prostaglandin D2 MaxSpecStandardProst-5-en-1-oic acid, 9-hydroxy-11,15-dioxo-, (5Z,9α)-
15-Oxo-13,14-dihydro-PGD2(5Z,9alpha)-9-Hydroxy-11,15-dioxoprost-5-en-1-oic acid13,14-dihydro-15-keto Prostaglandin D2 Lipid Maps(R) MS StandardDK-PGD213,14-dihydro-15-oxo PGD2DTXSID901357883DhkPGD2LMFA03010022

Properties

Computed structural properties

XLogP
2.4
Topological polar surface area
91.7 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
13
Heavy atoms
25
Formal charge
0
Complexity
469

Experimental & physicochemical properties

LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
Collision Cross Section186.8 Ų [M-H2O-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

Physicochemical properties

Boiling point
542.1 · 542.1±40.0 °C(Predicted)
Density
1.086 · 1.086±0.06 g/cm3(Predicted)
solubility
50 mg/mlDMSO: · DMF: 50 mg/mlDMSO: 30 mg/mlEthanol: 50 mg/mlPBS pH 7.2: 2.5 mg/ml
pka
4.76 · 4.76±0.10(Predicted)
Symbol(GHS)
2 · GHS02,GHS07
Signal word
Danger
Hazard statements
225 · H225-H319-H336
Precautionary statements
210 · P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Danger
Symbol(GHS)
GHS02,GHS07
Hazard statements
H225-H319-H336
Precautionary statements
P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501

Chemistry & industry

Pharmacology

Cellular LocationsMembrane
Applications · 2 items

Description13,14-dihydro-15-keto Prostaglandin D2 (13,14-dihydro-15-keto PGD2) is a metabolite of PGD2 which is formed through the 15-hydroxy PGDH pathway. 13,14-dihydro-15-keto PGD2 was recently identified as a selective agonist for the CRTH2/DP2 receptor. It also inhibits ion flux in a canine colonic mucosa preparation. In humans, 13,14-dihydro-15-keto PGD2 is further metabolized to give 11β-hydroxy compounds which have also undergone β-oxidation of one or both side chains. Virtually no 13,14-dihydro-15-keto PGD2 survives intact in the urine.

Uses13,14-Dihydro-15-keto-PGD2 is a metabolite of Prostaglandin D2 (CAT# P838575) and a selective CRTh2/DP2 receptor agonist. CRTh2/DP2 receptors play crucial roles in atopic dermatitis, asthma, and other inflammatory diseases.

Additional notes

DefinitionChEBI: 13,14-dihydro-15-ketoprostaglandin D2 is a prostaglandins D. It has a role as a metabolite. It is functionally related to a prostaglandin D2.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

3 records
New reaction record
HRID 846684 reaction equation
HRID 846684As productuspto-grants-1992_08
HRID 1461013 reaction equation
HRID 1461013As productuspto-grants-1991_12
HRID 1734706 reaction equation
HRID 1734706As productuspto-grants-1996_07

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
59894-07-4
PubChem CID
5283036
DTXSID
DTXSID901357883
ChEBI
CHEBI:72603
UNII
ULX4SW2MF7
Nikkaji
J428.388K